Efficient temporally‐controlled targeted mutagenesis in smooth muscle cells of the adult mouse
Citations Over Time
Abstract
To generate temporally-controlled targeted somatic mutations selectively and efficiently in smooth muscles, we have established a transgenic SMA-Cre-ER(T2) mouse line in which the expression of the Tamoxifen-dependent Cre-ER(T2) recombinase is under the control of a large genomic DNA segment of the mouse smooth muscle alpha actin (SMA) gene, contained in a Bacterial artificial chromosome (Bac). In this transgenic mouse line, Cre-ER(T2)-mediated recombination of LoxP-flanked target DNA is strictly Tamoxifen-dependent, and efficient in both vascular and visceral smooth muscle cells. Moreover, with the exception of few cardiomyocytes, LoxP-flanked DNA excision is restricted to smooth muscle cells. Thus, SMA-Cre-ER(T2) mice should be of great value to analyze gene function in smooth muscles, and to establish new animal models of human smooth muscle disorders.
Related Papers
- → Cre/ loxP Recombination System and Gene Targeting(2003)176 cited
- → Removal of the floxed neo gene from a conditional knockout allele by the adenoviral Cre recombinase in vivo(2001)64 cited
- → Keratinocyte-specific knockout mice models via Cre–loxP recombination system(2020)2 cited
- → Research progress of Cre/LoxP system in the eyes of animal model(2019)
- → Gene targeting vectors -considerations and use of loxP(1997)